Skip to content

Comparison Of Effect Of Intraarticular Growth Factor Concentrate Injection And Intraarticular Normal Saline Injection in Knee Osteoarthritis.

The Effect Of Intraarticular Growth Factor Concentrate Injection In Knee Osteoarthritis - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/079931
Enrollment
72
Registered
2025-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Intraarticular Injection of Growth Factor Concentrate: Patients will be recruited from the OPD after applying ACR criteria & KL Grade Il and III on X-RAY KNEE AP/LAT (STANDING) and appl

Sponsors

Teerthankar Mahaveer Medical College and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of either age group Diagnosed with Osteoarthritis Knee as per American College of Rheumatology (ACR) 2019 criteria. Among the above patients who are diagnosed with Grade II and III Osteoarthritis of the knee joint according to the Kellgren-Lawrence scale are selected.

Exclusion criteria

Exclusion criteria: 1.Any known malignancy 2.Gouty Arthritis /inflammatory arthritis, Secondary Osteoarthritis 3.Active knee infection. 4.Disorders of Bleeding 5.Uncontrolled Diabetes Mellitus 6.Ligamentous instability of knee (MRI DIAGNOSED)  7.Contraindication to MRI 8.Any history of previous intraarticular steroid injection

Design outcomes

Primary

MeasureTime frame
1.To assess and compare the functional outcome in patients of Knee Osteoarthritis before each GFC/NS injection and at 6 months and at 9 months and study their effect. 2.To assess and compare the Radiological outcome with the help of WORMS score and X-Ray in patients of Knee Osteoarthritis and observe the changes at the end of 9 months.Timepoint: 1,2,6 and 9 months

Secondary

MeasureTime frame
1.To assess and compare the cartilage degeneration with the help of Biochemical marker Serum Coll2-1NO2 levels at the final follow-up and compared to the baseline serum levels to analyse the effects of both GFC and NS on its level in the body.Timepoint: 1,2,6 and 9 months

Countries

India

Contacts

Public ContactDr Amit Saraf

Teerthankar Mahaveer Medical College and Research Centre

amitsaraf_75@yahoo.com9780029750

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026